225Ac-TR2205
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 225Ac-TR2205, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer. [EARLY_Phase 1]